Skip to main content

Table 1 Main results from individual patients

From: Clinical outcomes of patients treated with intravenous zanamivir for severe influenza A(H1N1)pdm09 infection: a case report series

 

Pt #1

Pt #2

Pt #3

Pt #4

Age (years)

47

59

37

58

SOFA score at ICU admission

13

13

13

14

Time spent under ECMO (days)

8

6

5

8

Time spent under MV (days)

13

18

8

21

Day of influenza A (H1N1)pdm09 virus detection

0

0

0

1

Day of first negative influenza A(H1N1)pdm09 virus

15

20

12

13

Length of zanamivir therapy (days)

11

17

11

11

Superinfection by MDR

 Ab

Yes

No

No

Yes

 CR-Kp

Yes

Yes

Yes

No

 Treatment

colistin+ ceftazidime/avibactam

colistin+ meropenem

colistin+ meropenem+ ertapenem

colistin+ tigecycline+ rifampicin

  1. SOFA Sequential Organ Failure Assessment, ICU Intensive Care Unit, ECMO Extra-Corporeal Membrane Oxygenation, MV Mechanical Ventilation, MDR Multi-Drug Resistant bacteria, Ab Acinetobacter baumannii, CR-Kp Carbapenem Resistant Klebsiella pneumonia